NP / PA
Hujus, Amy
Hujus, Amy was paid $222K by Medicaid between Feb 2018 and Apr 2023, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoHUJUS, AMY
MIDDLETOWN, NY 10941
MIDDLETOWN, NY 10941
33aNPI1730119439assigned 07/05/2006
33bProvider typePhysician Assistant
28Total paid$222K
24GClaims2,100
24DCodes billed12
24AFirst – last monthFeb 2018 – Apr 2023
Compared with peers
Next to other Physician Assistant providers in New York
Rank by total paid#20 of 263
Median peer was paid$3K
This provider vs. median68×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39 | $3K | |
| 2019 | 236 | $23K | |
| 2020 | 548 | $47K | |
| 2021 | 440 | $51K | |
| 2022 | 742 | $85K | |
| 2023 | 95 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 747 | 743 | $69K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 25% | 415 | 412 | $56K |
| S9083 | Global fee urgent care centers | 24% | 349 | 347 | $52K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.7% | 158 | 158 | $19K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8.4% | 204 | 203 | $19K |
| 87631 | 1.0% | 16 | 16 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 54 | 54 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 38 | 38 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 26 | 26 | $701.80 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | 14 | $231.42 |
| 87070 | <1% | 12 | 12 | $103.44 | |
| 99080 | 0% | 67 | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.